Vedanta Biosciences Receives $50,000,000 New Financing

  • Feed Type
  • Date
    6/7/2016
  • Company Name
    Vedanta Biosciences
  • Mailing Address
    19 Blackstone Street 3rd Floor Cambridge, MA 02139 USA
  • Company Description
    Vedanta Biosciences was founded by PureTech and a team of world renowned experts in immunology and microbiology. Vedanta Biosciences is developing a class of drugs that work by modulating the human microbiome, with an initial emphasis in autoimmune and inflammatory diseases.
  • Website
    http://www.vedantabio.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $50,000,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds from the financing will be used to advance multiple clinical studies in infectious and autoimmune diseases and to scale the company’s technology platform.
  • M&A Terms
  • Venture Investor
    Rock Springs Capital
  • Venture Investor
    INVESCO Private Capital
  • Venture Investor
    Undisclosed

Trending on Xconomy